NCT00344721View on ClinicalTrials.gov

A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Dry Eye Syndrome
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acid supplement

Participants receive four oral doses of soft-gel capsules to be taken daily (QD) for 3 months.

DIETARY_SUPPLEMENT

Placebo

Participants receive four oral doses of soft-gel capsules containing wheat germ oil to be taken daily for 3 months.

Trial Locations (1)

75390-8866

University of Texas Southwestern Medical Center at Dallas, Dallas

Sponsors

Collaborators (1)

Advanced Vision Research
All Listed Sponsors
collaborator

Advanced Vision Research

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00344721 - A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome | Biotech Hunter | Biotech Hunter